CovidV1, PascalFrancis, Checkpoint, bibRecord, 000015

Respiratory Viruses in Adults With Community-Acquired Pneumonia

Identifieur interne : 000015 ( PascalFrancis/Checkpoint ); précédent : 000014; suivant : 000016

Respiratory Viruses in Adults With Community-Acquired Pneumonia

Auteurs : David Lieberman [Israël] ; Avi Shimoni [Israël] ; Yonat Shemer-Avni [Israël] ; Ayelet Keren-Naos [Israël] ; Rachel Shtainberg [Israël] ; Devora Lieberman [Israël]

Source :

Chest : (American College of Chest Physicians) [ 0012-3692 ] ; 2010.

RBID : Pascal:10-0485663

Descripteurs français

Pascal (Inist)
- Pneumonie, Infection communautaire, Voie respiratoire, Adulte, Anesthésie, Appareil circulatoire, Cardiologie.
Wicri :
- topic : Adulte.

English descriptors

KwdEn :
- Adult, Anesthesia, Cardiology, Circulatory system, Community acquired infection, Pneumonia, Respiratory tract.

Abstract

Background: Use of nucleic acid amplification techniques has increased the identification of respiratory viruses (RVs) in adult patients with community-acquired pneumonia (CAP). The objectives of the present study were to identify RV in patients with CAP using three different sampling methods and to compare CAP virus proportions and types with two comparison groups. Methods: The study population included 183 adult patients with CAP, 450 control subjects, and 201 patients with nonpneumonic lower respiratory tract infection (NPLRTI). Each participant was sampled by oropharyngeal swab, nasopharyngeal swab, and nasopharyngeal washing, and the samples were tested for detection of 12 RVs by multiplex TaqMan Hydrolysis probe-based real-time polymerase chain reaction (Integrated DNA Technology; Coralville, IA). Results: At least one RV was identified in 58 patients with CAP (31.7%) compared with 32 (7.1%) in control subjects and 104 (51.7%) in patients with NPLRTI (P < .01 and P < .01, respectively). Corona-viruses were identified in 24 (13.1%) patients with CAP, compared with 17 (3.8%) in control subjects, and 21 (10.4%) patients with NPLRTI. Respiratory syncytial virus was identified in 13 (7.1%), four (0.9%), and seven (3.5%); rhinovirus in nine (4.9%), nine (2.0%), and 15 (7.5%); and influenza virus in eight (4.4%), two (0.4%), and 63 (31.3%) patients with CAP, control subjects, and patients with NPLRTI, respectively. Conclusions: The proportion of RV involvement in CAP is higher than previously reported. The proportion of RV identified in healthy subjects is significantly lower than in CAP, but it is not zero and should be weighed when interpreting corresponding proportions among patients.

Affiliations:

Israël

Links toward previous steps (curation, corpus...)

to stream PascalFrancis, to step Corpus: 000016
to stream PascalFrancis, to step Curation: 000043

Links to Exploration step

Pascal:10-0485663

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Respiratory Viruses in Adults With Community-Acquired Pneumonia</title>
<author><name sortKey="Lieberman, David" sort="Lieberman, David" uniqKey="Lieberman D" first="David" last="Lieberman">David Lieberman</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Pulmonary Unit, Soroka Medical Center and the Faculty of Health Sciences, Ben-Gurion University of the Negev</s1>
<s2>Beer-Sheva</s2>
<s3>ISR</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>Israël</country>
<wicri:noRegion>Beer-Sheva</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Division of Internal Medicine, Soroka Medical Center and the Faculty of Health Sciences, Ben-Gurion University of the Negev</s1>
<s2>Beer-Sheva</s2>
<s3>ISR</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>Israël</country>
<wicri:noRegion>Beer-Sheva</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Shimoni, Avi" sort="Shimoni, Avi" uniqKey="Shimoni A" first="Avi" last="Shimoni">Avi Shimoni</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Division of Internal Medicine, Soroka Medical Center and the Faculty of Health Sciences, Ben-Gurion University of the Negev</s1>
<s2>Beer-Sheva</s2>
<s3>ISR</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>Israël</country>
<wicri:noRegion>Beer-Sheva</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Clinical Virology Laboratory, Soroka Medical Center and the Faculty of Health Sciences, Ben-Gurion University of the Negev</s1>
<s2>Beer-Sheva</s2>
<s3>ISR</s3>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>Israël</country>
<wicri:noRegion>Beer-Sheva</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Shemer Avni, Yonat" sort="Shemer Avni, Yonat" uniqKey="Shemer Avni Y" first="Yonat" last="Shemer-Avni">Yonat Shemer-Avni</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Pulmonary Unit, Soroka Medical Center and the Faculty of Health Sciences, Ben-Gurion University of the Negev</s1>
<s2>Beer-Sheva</s2>
<s3>ISR</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>Israël</country>
<wicri:noRegion>Beer-Sheva</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Keren Naos, Ayelet" sort="Keren Naos, Ayelet" uniqKey="Keren Naos A" first="Ayelet" last="Keren-Naos">Ayelet Keren-Naos</name>
<affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Clinical Virology Laboratory, Soroka Medical Center and the Faculty of Health Sciences, Ben-Gurion University of the Negev</s1>
<s2>Beer-Sheva</s2>
<s3>ISR</s3>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>Israël</country>
<wicri:noRegion>Beer-Sheva</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Shtainberg, Rachel" sort="Shtainberg, Rachel" uniqKey="Shtainberg R" first="Rachel" last="Shtainberg">Rachel Shtainberg</name>
<affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Clinical Virology Laboratory, Soroka Medical Center and the Faculty of Health Sciences, Ben-Gurion University of the Negev</s1>
<s2>Beer-Sheva</s2>
<s3>ISR</s3>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>Israël</country>
<wicri:noRegion>Beer-Sheva</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Lieberman, Devora" sort="Lieberman, Devora" uniqKey="Lieberman D" first="Devora" last="Lieberman">Devora Lieberman</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Division of Internal Medicine, Soroka Medical Center and the Faculty of Health Sciences, Ben-Gurion University of the Negev</s1>
<s2>Beer-Sheva</s2>
<s3>ISR</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>Israël</country>
<wicri:noRegion>Beer-Sheva</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1"><inist:fA14 i1="04"><s1>Department of Geriatric Medicine, Soroka Medical Center and the Faculty of Health Sciences, Ben-Gurion University of the Negev</s1>
<s2>Beer-Sheva</s2>
<s3>ISR</s3>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>Israël</country>
<wicri:noRegion>Beer-Sheva</wicri:noRegion>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">10-0485663</idno>
<date when="2010">2010</date>
<idno type="stanalyst">PASCAL 10-0485663 INIST</idno>
<idno type="RBID">Pascal:10-0485663</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000016</idno>
<idno type="wicri:Area/PascalFrancis/Curation">000043</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">000015</idno>
<idno type="wicri:explorRef" wicri:stream="PascalFrancis" wicri:step="Checkpoint">000015</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Respiratory Viruses in Adults With Community-Acquired Pneumonia</title>
<author><name sortKey="Lieberman, David" sort="Lieberman, David" uniqKey="Lieberman D" first="David" last="Lieberman">David Lieberman</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Pulmonary Unit, Soroka Medical Center and the Faculty of Health Sciences, Ben-Gurion University of the Negev</s1>
<s2>Beer-Sheva</s2>
<s3>ISR</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>Israël</country>
<wicri:noRegion>Beer-Sheva</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Division of Internal Medicine, Soroka Medical Center and the Faculty of Health Sciences, Ben-Gurion University of the Negev</s1>
<s2>Beer-Sheva</s2>
<s3>ISR</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>Israël</country>
<wicri:noRegion>Beer-Sheva</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Shimoni, Avi" sort="Shimoni, Avi" uniqKey="Shimoni A" first="Avi" last="Shimoni">Avi Shimoni</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Division of Internal Medicine, Soroka Medical Center and the Faculty of Health Sciences, Ben-Gurion University of the Negev</s1>
<s2>Beer-Sheva</s2>
<s3>ISR</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>Israël</country>
<wicri:noRegion>Beer-Sheva</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Clinical Virology Laboratory, Soroka Medical Center and the Faculty of Health Sciences, Ben-Gurion University of the Negev</s1>
<s2>Beer-Sheva</s2>
<s3>ISR</s3>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>Israël</country>
<wicri:noRegion>Beer-Sheva</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Shemer Avni, Yonat" sort="Shemer Avni, Yonat" uniqKey="Shemer Avni Y" first="Yonat" last="Shemer-Avni">Yonat Shemer-Avni</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Pulmonary Unit, Soroka Medical Center and the Faculty of Health Sciences, Ben-Gurion University of the Negev</s1>
<s2>Beer-Sheva</s2>
<s3>ISR</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>Israël</country>
<wicri:noRegion>Beer-Sheva</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Keren Naos, Ayelet" sort="Keren Naos, Ayelet" uniqKey="Keren Naos A" first="Ayelet" last="Keren-Naos">Ayelet Keren-Naos</name>
<affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Clinical Virology Laboratory, Soroka Medical Center and the Faculty of Health Sciences, Ben-Gurion University of the Negev</s1>
<s2>Beer-Sheva</s2>
<s3>ISR</s3>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>Israël</country>
<wicri:noRegion>Beer-Sheva</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Shtainberg, Rachel" sort="Shtainberg, Rachel" uniqKey="Shtainberg R" first="Rachel" last="Shtainberg">Rachel Shtainberg</name>
<affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Clinical Virology Laboratory, Soroka Medical Center and the Faculty of Health Sciences, Ben-Gurion University of the Negev</s1>
<s2>Beer-Sheva</s2>
<s3>ISR</s3>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>Israël</country>
<wicri:noRegion>Beer-Sheva</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Lieberman, Devora" sort="Lieberman, Devora" uniqKey="Lieberman D" first="Devora" last="Lieberman">Devora Lieberman</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Division of Internal Medicine, Soroka Medical Center and the Faculty of Health Sciences, Ben-Gurion University of the Negev</s1>
<s2>Beer-Sheva</s2>
<s3>ISR</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>Israël</country>
<wicri:noRegion>Beer-Sheva</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1"><inist:fA14 i1="04"><s1>Department of Geriatric Medicine, Soroka Medical Center and the Faculty of Health Sciences, Ben-Gurion University of the Negev</s1>
<s2>Beer-Sheva</s2>
<s3>ISR</s3>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>Israël</country>
<wicri:noRegion>Beer-Sheva</wicri:noRegion>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">Chest : (American College of Chest Physicians)</title>
<title level="j" type="abbreviated">Chest : (Amer. Coll. Chest Phys.)</title>
<idno type="ISSN">0012-3692</idno>
<imprint><date when="2010">2010</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Chest : (American College of Chest Physicians)</title>
<title level="j" type="abbreviated">Chest : (Amer. Coll. Chest Phys.)</title>
<idno type="ISSN">0012-3692</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term>
<term>Anesthesia</term>
<term>Cardiology</term>
<term>Circulatory system</term>
<term>Community acquired infection</term>
<term>Pneumonia</term>
<term>Respiratory tract</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Pneumonie</term>
<term>Infection communautaire</term>
<term>Voie respiratoire</term>
<term>Adulte</term>
<term>Anesthésie</term>
<term>Appareil circulatoire</term>
<term>Cardiologie</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Adulte</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Background: Use of nucleic acid amplification techniques has increased the identification of respiratory viruses (RVs) in adult patients with community-acquired pneumonia (CAP). The objectives of the present study were to identify RV in patients with CAP using three different sampling methods and to compare CAP virus proportions and types with two comparison groups. Methods: The study population included 183 adult patients with CAP, 450 control subjects, and 201 patients with nonpneumonic lower respiratory tract infection (NPLRTI). Each participant was sampled by oropharyngeal swab, nasopharyngeal swab, and nasopharyngeal washing, and the samples were tested for detection of 12 RVs by multiplex TaqMan Hydrolysis probe-based real-time polymerase chain reaction (Integrated DNA Technology; Coralville, IA). Results: At least one RV was identified in 58 patients with CAP (31.7%) compared with 32 (7.1%) in control subjects and 104 (51.7%) in patients with NPLRTI (P < .01 and P < .01, respectively). Corona-viruses were identified in 24 (13.1%) patients with CAP, compared with 17 (3.8%) in control subjects, and 21 (10.4%) patients with NPLRTI. Respiratory syncytial virus was identified in 13 (7.1%), four (0.9%), and seven (3.5%); rhinovirus in nine (4.9%), nine (2.0%), and 15 (7.5%); and influenza virus in eight (4.4%), two (0.4%), and 63 (31.3%) patients with CAP, control subjects, and patients with NPLRTI, respectively. Conclusions: The proportion of RV involvement in CAP is higher than previously reported. The proportion of RV identified in healthy subjects is significantly lower than in CAP, but it is not zero and should be weighed when interpreting corresponding proportions among patients.</div>
</front>
</TEI>
<inist><standard h6="B"><pA><fA01 i1="01" i2="1"><s0>0012-3692</s0>
</fA01>
<fA02 i1="01"><s0>CHETBF</s0>
</fA02>
<fA03 i2="1"><s0>Chest : (Amer. Coll. Chest Phys.)</s0>
</fA03>
<fA05><s2>138</s2>
</fA05>
<fA06><s2>4</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG"><s1>Respiratory Viruses in Adults With Community-Acquired Pneumonia</s1>
</fA08>
<fA11 i1="01" i2="1"><s1>LIEBERMAN (David)</s1>
</fA11>
<fA11 i1="02" i2="1"><s1>SHIMONI (Avi)</s1>
</fA11>
<fA11 i1="03" i2="1"><s1>SHEMER-AVNI (Yonat)</s1>
</fA11>
<fA11 i1="04" i2="1"><s1>KEREN-NAOS (Ayelet)</s1>
</fA11>
<fA11 i1="05" i2="1"><s1>SHTAINBERG (Rachel)</s1>
</fA11>
<fA11 i1="06" i2="1"><s1>LIEBERMAN (Devora)</s1>
</fA11>
<fA14 i1="01"><s1>Pulmonary Unit, Soroka Medical Center and the Faculty of Health Sciences, Ben-Gurion University of the Negev</s1>
<s2>Beer-Sheva</s2>
<s3>ISR</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
</fA14>
<fA14 i1="02"><s1>Division of Internal Medicine, Soroka Medical Center and the Faculty of Health Sciences, Ben-Gurion University of the Negev</s1>
<s2>Beer-Sheva</s2>
<s3>ISR</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>6 aut.</sZ>
</fA14>
<fA14 i1="03"><s1>Clinical Virology Laboratory, Soroka Medical Center and the Faculty of Health Sciences, Ben-Gurion University of the Negev</s1>
<s2>Beer-Sheva</s2>
<s3>ISR</s3>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</fA14>
<fA14 i1="04"><s1>Department of Geriatric Medicine, Soroka Medical Center and the Faculty of Health Sciences, Ben-Gurion University of the Negev</s1>
<s2>Beer-Sheva</s2>
<s3>ISR</s3>
<sZ>6 aut.</sZ>
</fA14>
<fA20><s1>811-816</s1>
</fA20>
<fA21><s1>2010</s1>
</fA21>
<fA23 i1="01"><s0>ENG</s0>
</fA23>
<fA43 i1="01"><s1>INIST</s1>
<s2>7627</s2>
<s5>354000193278410110</s5>
</fA43>
<fA44><s0>0000</s0>
<s1>© 2010 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45><s0>19 ref.</s0>
</fA45>
<fA47 i1="01" i2="1"><s0>10-0485663</s0>
</fA47>
<fA60><s1>P</s1>
</fA60>
<fA61><s0>A</s0>
</fA61>
<fA64 i1="01" i2="1"><s0>Chest : (American College of Chest Physicians)</s0>
</fA64>
<fA66 i1="01"><s0>USA</s0>
</fA66>
<fC01 i1="01" l="ENG"><s0>Background: Use of nucleic acid amplification techniques has increased the identification of respiratory viruses (RVs) in adult patients with community-acquired pneumonia (CAP). The objectives of the present study were to identify RV in patients with CAP using three different sampling methods and to compare CAP virus proportions and types with two comparison groups. Methods: The study population included 183 adult patients with CAP, 450 control subjects, and 201 patients with nonpneumonic lower respiratory tract infection (NPLRTI). Each participant was sampled by oropharyngeal swab, nasopharyngeal swab, and nasopharyngeal washing, and the samples were tested for detection of 12 RVs by multiplex TaqMan Hydrolysis probe-based real-time polymerase chain reaction (Integrated DNA Technology; Coralville, IA). Results: At least one RV was identified in 58 patients with CAP (31.7%) compared with 32 (7.1%) in control subjects and 104 (51.7%) in patients with NPLRTI (P < .01 and P < .01, respectively). Corona-viruses were identified in 24 (13.1%) patients with CAP, compared with 17 (3.8%) in control subjects, and 21 (10.4%) patients with NPLRTI. Respiratory syncytial virus was identified in 13 (7.1%), four (0.9%), and seven (3.5%); rhinovirus in nine (4.9%), nine (2.0%), and 15 (7.5%); and influenza virus in eight (4.4%), two (0.4%), and 63 (31.3%) patients with CAP, control subjects, and patients with NPLRTI, respectively. Conclusions: The proportion of RV involvement in CAP is higher than previously reported. The proportion of RV identified in healthy subjects is significantly lower than in CAP, but it is not zero and should be weighed when interpreting corresponding proportions among patients.</s0>
</fC01>
<fC02 i1="01" i2="X"><s0>002B11</s0>
</fC02>
<fC02 i1="02" i2="X"><s0>002B12</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE"><s0>Pneumonie</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG"><s0>Pneumonia</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA"><s0>Neumonía</s0>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE"><s0>Infection communautaire</s0>
<s2>NM</s2>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG"><s0>Community acquired infection</s0>
<s2>NM</s2>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA"><s0>Infección comunitaria</s0>
<s2>NM</s2>
<s5>02</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE"><s0>Voie respiratoire</s0>
<s5>09</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG"><s0>Respiratory tract</s0>
<s5>09</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA"><s0>Vía respiratoria</s0>
<s5>09</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE"><s0>Adulte</s0>
<s5>10</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG"><s0>Adult</s0>
<s5>10</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA"><s0>Adulto</s0>
<s5>10</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE"><s0>Anesthésie</s0>
<s5>11</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG"><s0>Anesthesia</s0>
<s5>11</s5>
</fC03>
<fC03 i1="05" i2="X" l="SPA"><s0>Anestesia</s0>
<s5>11</s5>
</fC03>
<fC03 i1="06" i2="X" l="FRE"><s0>Appareil circulatoire</s0>
<s5>12</s5>
</fC03>
<fC03 i1="06" i2="X" l="ENG"><s0>Circulatory system</s0>
<s5>12</s5>
</fC03>
<fC03 i1="06" i2="X" l="SPA"><s0>Aparato circulatorio</s0>
<s5>12</s5>
</fC03>
<fC03 i1="07" i2="X" l="FRE"><s0>Cardiologie</s0>
<s5>13</s5>
</fC03>
<fC03 i1="07" i2="X" l="ENG"><s0>Cardiology</s0>
<s5>13</s5>
</fC03>
<fC03 i1="07" i2="X" l="SPA"><s0>Cardiología</s0>
<s5>13</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE"><s0>Homme</s0>
</fC07>
<fC07 i1="01" i2="X" l="ENG"><s0>Human</s0>
</fC07>
<fC07 i1="01" i2="X" l="SPA"><s0>Hombre</s0>
</fC07>
<fC07 i1="02" i2="X" l="FRE"><s0>Pathologie de l'appareil respiratoire</s0>
<s5>37</s5>
</fC07>
<fC07 i1="02" i2="X" l="ENG"><s0>Respiratory disease</s0>
<s5>37</s5>
</fC07>
<fC07 i1="02" i2="X" l="SPA"><s0>Aparato respiratorio patología</s0>
<s5>37</s5>
</fC07>
<fC07 i1="03" i2="X" l="FRE"><s0>Pathologie des poumons</s0>
<s5>38</s5>
</fC07>
<fC07 i1="03" i2="X" l="ENG"><s0>Lung disease</s0>
<s5>38</s5>
</fC07>
<fC07 i1="03" i2="X" l="SPA"><s0>Pulmón patología</s0>
<s5>38</s5>
</fC07>
<fN21><s1>319</s1>
</fN21>
<fN44 i1="01"><s1>OTO</s1>
</fN44>
<fN82><s1>OTO</s1>
</fN82>
</pA>
</standard>
</inist>
<affiliations><list><country><li>Israël</li>
</country>
</list>
<tree><country name="Israël"><noRegion><name sortKey="Lieberman, David" sort="Lieberman, David" uniqKey="Lieberman D" first="David" last="Lieberman">David Lieberman</name>
</noRegion>
<name sortKey="Keren Naos, Ayelet" sort="Keren Naos, Ayelet" uniqKey="Keren Naos A" first="Ayelet" last="Keren-Naos">Ayelet Keren-Naos</name>
<name sortKey="Lieberman, David" sort="Lieberman, David" uniqKey="Lieberman D" first="David" last="Lieberman">David Lieberman</name>
<name sortKey="Lieberman, Devora" sort="Lieberman, Devora" uniqKey="Lieberman D" first="Devora" last="Lieberman">Devora Lieberman</name>
<name sortKey="Lieberman, Devora" sort="Lieberman, Devora" uniqKey="Lieberman D" first="Devora" last="Lieberman">Devora Lieberman</name>
<name sortKey="Shemer Avni, Yonat" sort="Shemer Avni, Yonat" uniqKey="Shemer Avni Y" first="Yonat" last="Shemer-Avni">Yonat Shemer-Avni</name>
<name sortKey="Shimoni, Avi" sort="Shimoni, Avi" uniqKey="Shimoni A" first="Avi" last="Shimoni">Avi Shimoni</name>
<name sortKey="Shimoni, Avi" sort="Shimoni, Avi" uniqKey="Shimoni A" first="Avi" last="Shimoni">Avi Shimoni</name>
<name sortKey="Shtainberg, Rachel" sort="Shtainberg, Rachel" uniqKey="Shtainberg R" first="Rachel" last="Shtainberg">Rachel Shtainberg</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/CovidV1/Data/PascalFrancis/Checkpoint

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000015 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Checkpoint/biblio.hfd -nk 000015 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    CovidV1
   |flux=    PascalFrancis
   |étape=   Checkpoint
   |type=    RBID
   |clé=     Pascal:10-0485663
   |texte=   Respiratory Viruses in Adults With Community-Acquired Pneumonia
}}

This area was generated with Dilib version V0.6.33.
Data generation: Fri Mar 27 18:14:15 2020. Site generation: Sun Jan 31 15:15:08 2021

	Serveur d'exploration Covid
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration Covid

Respiratory Viruses in Adults With Community-Acquired Pneumonia

Respiratory Viruses in Adults With Community-Acquired Pneumonia

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri